Usefulness of the blood chemistry screening associated with DXA imaging in a case of secondary osteoporosis in a young adult

Usefulness of the blood chemistry screening associated with DXA imaging in a case of secondary osteoporosis in a young adult

Authors

  • Valerio Massimo Magro Department of Internal Medicine and Geriatrics, University of Campania “Luigi Vanvitelli”, Naples
  • Michele Caturano Geriatrician, ASL NA1 Centro, Naples
  • Giovanni Scala Medical Director and Geriatrician Manager at the Center Home Care (CAD), ASL Roma 2, Rome

DOI:

https://doi.org/10.7175/cmi.v11i1.1288

Keywords:

Osteoporosis, Young Patient, Hematologic Tests, Multiple Myeloma

Abstract

Multiple myeloma is rare in young patients and may be undiagnosed or characterized by a significant delay in diagnosis.

We report the association of stage I myeloma (according to Durie-Salmon classification) and osteoporosis in a 37-year-old male patient complaining of worsening pain in the spine. Pain attacks resulted in increases in blood pressure with hypertensive episodes. The investigations (on the basis of an unclear radiological picture and the presence of hypertensive state) led to the diagnosis of low grade osteoporosis. Since the young subject was symptomatic at the diagnosis, we continued evaluations on the basis of imaging data (DXA) and laboratory tests, revealing the presence of multiple myeloma. Clinical, laboratory, and therapeutic implications of this clinical case are discussed.

References

Jurczyszyn A, Nahi H, Avivi I, et al. Characteristics and outcomes of patients with multiple myeloma aged 21-40 years versus 41-60 years: a multi-institutional case-control study. Br J Haematol 2016; 175: 884-91; https://doi.org/10.1111/bjh.14328

Mirza F, Canalis E. Management of endocrine disease: Secondary osteoporosis: pathophysiology and management. Eur J Endocrinol 2015; 173: R131-R151; https://doi.org/10.1530/EJE-15-0118

Drake MT. Unveiling skeletal fragility in patients diagnosed with MGUS: no longer a condition of undetermined significance? J Bone Miner Res 2014; 29: 2529-33; https://doi.org/10.1002/jbmr.2387

Murray DL, Seningen JL, Dispenzieri A, et al. Laboratory persistence and clinical progression of small monoclonal abnormalities. Am J Clin Pathol 2012; 138: 609-13; https://doi.org/10.1309/AJCPT6OWWMHITA1Y

Dugan LO, Dugan DA, Dugan WM Jr. Back pain: the primrose path – a case report. Indiana Med 1990; 83: 114-6

Faiman B, Licata AA. New tools for detecting occult monoclonal gammopathy, a cause of secondary osteoporosis. Cleve Clin J Med 2010; 77: 273-8; https://doi.org/10.3949/ccjm.77a.09091

Bours SP, van den Bergh JP, van Geel TA, et al. Secondary osteoporosis and metabolic bone disease in patients 50 years and older with osteoporosis or with a recent clinical fracture: a clinical perspective. Curr Opin Rheumatol 2014; 26: 430-9; https://doi.org/10.1097/BOR.0000000000000074

Bours SP, van Geel TA, Geusens PP, et al. Contributors to secondary osteoporosis and metabolic bone diseases in patients presenting with a clinical fracture. J Clin Endocrinol Metab 2011; 96: 1360-7; https://doi.org/10.1210/jc.2010-2135

Camacho PM, Petak SM, Binkley N, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis – 2016 – Executive summary. Endocr Pract 2016; 22 (Suppl 4): 1-42; https://doi.org/10.4158/EP161435.GL; https://doi.org/10.4158/EP161435.ESGL; https://doi.org/10.4158/EP161208.GL

Adami S, Bertoldo F, Brandi ML, et al. Guidelines for the diagnosis, prevention and treatment of osteoporosis. Reumatismo 2009; 61: 1-25

Harrington J, Sochett E. The child with multiple fractures, what next? Pediatr Clin North Am 2015; 62: 841-55; https://doi.org/10.1016/j.pcl.2015.04.006

Järveläinen H, Remes K, Viikari J. A severe osteoporosis in a middle-aged man. Duodecim 1999; 115: 2473-6

Downloads

Published

2017-06-08

Issue

Vol. 11 No. 1 (2017)

Section

Case report

License

Authors who publish with this journal agree to the following terms:
    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non-Commercial 4.0 Licence that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. The Publication Agreement can be downloaded here, and should be signed by the Authors and sent to the Publisher when the article has been accepted for publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
    4. Authors are permitted to post their work online after publication (the article must link to publisher version, in html format)